BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11959151)

  • 21. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.
    Mukae H; Kohno S; Morikawa N; Kadota J; Matsukura S; Hara K
    Microbiol Immunol; 1994; 38(1):55-62. PubMed ID: 8052162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.
    Sarkis S; Belrose G; Peloponese JM; Olindo S; Césaire R; Mesnard JM; Gross A
    J Clin Virol; 2013 Sep; 58(1):295-8. PubMed ID: 23756056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
    Rajaei T; Farajifard H; Rezaee SA; Azarpazhooh MR; Mahmoudi M; Valizadeh N; Rafatpanah H
    Med Microbiol Immunol; 2019 Oct; 208(5):641-650. PubMed ID: 30341468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease.
    Trindade BC; Sorgi CA; Nicolete LD; Malta TM; Pinto MT; Takayanagui OM; Covas DT; Martins Filho OA; Kashima S; Faccioli LH
    PLoS One; 2012; 7(12):e51873. PubMed ID: 23284797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
    Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; Wucherpfennig KW; Bangham CR; Osame M; Saito M
    J Infect Dis; 2007 Dec; 196(12):1761-72. PubMed ID: 18190256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis.
    Ochi H; Wu XM; Osoegawa M; Horiuchi I; Minohara M; Murai H; Ohyagi Y; Furuya H; Kira J
    J Neuroimmunol; 2001 Oct; 119(2):297-305. PubMed ID: 11585633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
    Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
    Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
    Nakamura T
    Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
    Yamauchi J; Coler-Reilly A; Sato T; Araya N; Yagishita N; Ando H; Kunitomo Y; Takahashi K; Tanaka Y; Shibagaki Y; Nishioka K; Nakajima T; Hasegawa Y; Utsunomiya A; Kimura K; Yamano Y
    J Infect Dis; 2015 Jan; 211(2):238-48. PubMed ID: 25104771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of neuronal interferon-gamma in the development of myelopathy in rats infected with human T-cell leukemia virus type 1.
    Miyatake Y; Ikeda H; Ishizu A; Baba T; Ichihashi T; Suzuki A; Tomaru U; Kasahara M; Yoshiki T
    Am J Pathol; 2006 Jul; 169(1):189-99. PubMed ID: 16816372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP.
    Enose-Akahata Y; Oh U; Ohayon J; Billioux BJ; Massoud R; Bryant BR; Vellucci A; Ngouth N; Cortese I; Waldmann TA; Jacobson S
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1383-1394. PubMed ID: 31402625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of cytokines, neurological disability, and disease duration in HAM/TSP patients.
    Muniz AL; Rodrigues W; Santos SB; de Jesus AR; Porto AF; Castro N; Oliveira-Filho J; Almeida JP; Moreno-Carvalho O; Carvalho EM
    Arq Neuropsiquiatr; 2006 Jun; 64(2A):217-21. PubMed ID: 16791359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil.
    Brito-Melo GE; Martins-Filho OA; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; Thorum GW; Barbosa-Stancioli EF;
    Scand J Immunol; 2002 Jun; 55(6):621-8. PubMed ID: 12028566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
    Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
    Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
    Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
    Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy.
    Watanabe H; Nakamura T; Nagasato K; Shirabe S; Ohishi K; Ichinose K; Nishiura Y; Chiyoda S; Tsujihata M; Nagataki S
    Arch Neurol; 1995 Mar; 52(3):276-80. PubMed ID: 7872881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.
    Enose-Akahata Y; Matsuura E; Oh U; Jacobson S
    PLoS Pathog; 2009 Dec; 5(12):e1000682. PubMed ID: 19997502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
    Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.